Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis
Iddo Magen, Nancy‐Sarah Yacovzada, Eran Yanowski, Anna M. L. Coenen-Stass, Julian Großkreutz, Ching‐Hua Lu, Linda Greensmith, Andrea Malaspina, Pietro Fratta, Eran Hornstein
The paper identifies miR-181 as a prognostic biomarker in ALS, showing it predicts higher mortality risk and improves prognosis prediction when combined with NfL.
Nature Neuroscience · Oct 28, 2021Peer-reviewedNeuroscience